Cite
HARVARD Citation
Chen, X. et al. (2022). Norcantharidin counteracts acquired everolimus resistance in renal cell carcinoma by dual inhibition of mammalian target of rapamycin complex 1 and complex 2 pathways in Vitro. Anti-cancer drugs. 33 (1), p. . [Online].